These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2563099

  • 1. Possible role for vitamin D in controlling breast cancer cell proliferation.
    Colston KW, Berger U, Coombes RC.
    Lancet; 1989 Jan 28; 1(8631):188-91. PubMed ID: 2563099
    [Abstract] [Full Text] [Related]

  • 2. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.
    Colston KW, Chander SK, Mackay AG, Coombes RC.
    Biochem Pharmacol; 1992 Aug 18; 44(4):693-702. PubMed ID: 1324683
    [Abstract] [Full Text] [Related]

  • 3. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L.
    J Natl Cancer Inst; 1997 Feb 05; 89(3):212-8. PubMed ID: 9017001
    [Abstract] [Full Text] [Related]

  • 4. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor.
    Colston K, Wilkinson JR, Coombes RC.
    Endocrinology; 1986 Jul 05; 119(1):397-403. PubMed ID: 3013595
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
    Mehta RR, Bratescu L, Graves JM, Green A, Mehta RG.
    Int J Oncol; 2000 Jan 05; 16(1):65-73. PubMed ID: 10601550
    [Abstract] [Full Text] [Related]

  • 6. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC.
    Biochem Pharmacol; 1992 Dec 15; 44(12):2273-80. PubMed ID: 1472092
    [Abstract] [Full Text] [Related]

  • 7. 1,25-dihydroxyvitamin D3 and breast cancer.
    Eisman JA, Suva LJ, Frampton RJ.
    Aust N Z J Surg; 1984 Feb 15; 54(1):17-20. PubMed ID: 6326729
    [Abstract] [Full Text] [Related]

  • 8. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M, Eisman JA, Sutherland RL.
    Cancer Res; 1988 May 15; 48(10):2734-9. PubMed ID: 2834048
    [Abstract] [Full Text] [Related]

  • 9. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 15; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 10. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone.
    Gross M, Kost SB, Ennis B, Stumpf W, Kumar R.
    J Bone Miner Res; 1986 Oct 15; 1(5):457-67. PubMed ID: 2845731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Oct 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer.
    Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6793-9. PubMed ID: 2824042
    [Abstract] [Full Text] [Related]

  • 14. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
    Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E, Ikeda K.
    Endocrinology; 1991 Aug 15; 129(2):832-7. PubMed ID: 1855478
    [Abstract] [Full Text] [Related]

  • 15. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S, Donaldson CA, Haussler MR.
    Cancer Res; 1984 May 15; 44(5):2103-9. PubMed ID: 6324995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.
    PLoS Med; 2007 Mar 15; 4(3):e103. PubMed ID: 17388667
    [Abstract] [Full Text] [Related]

  • 18. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
    Baran DT, Sorensen AM, Shalhoub V, Owen T, Oberdorf A, Stein G, Lian J.
    J Bone Miner Res; 1991 Dec 15; 6(12):1269-75. PubMed ID: 1665280
    [Abstract] [Full Text] [Related]

  • 19. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
    Eisman JA, Barkla DH, Tutton PJ.
    Cancer Res; 1987 Jan 01; 47(1):21-5. PubMed ID: 3024816
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.